Drugs https://doi.org/10.1007/s40265-018-0926-2 CORRECTION Anthony Markham Springer Nature 2018 Correction to: Drugs 78(7):781–785 (2018) any noncommercial use, duplication, adaptation, distribu- https://doi.org/10.1007/s40265-018-0907-5 tion and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the The article Ibalizumab: First Global Approval, written by source, provide a link to the Creative Commons license and Anthony Markham, was originally published Online First indicate if changes were made. without open access. After publication in volume 78, issue The original article was corrected. 7, pages 781–785 Theratechnologies Inc. requested that the Open Access This article is distributed under the terms of the article be Open Choice to make the article an open access Creative Commons Attribution-NonCommercial 4.0 International publication. Post-publication open access was funded by License (http://creativecommons.org/licenses/by-nc/4.0/), which per- Theratechnologies Inc. The article is forthwith distributed mits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appro- under the terms of the Creative Commons Attribution- priate credit to the original author(s) and the source, provide a link to NonCommercial 4.0 International License (http:// the Creative Commons license and indicate if changes were made. creativecommons.org/licenses/by-nc/4.0/), which permits The original article can be found online at https://doi.org/10.1007/ s40265-018-0907-5. & Anthony Markham email@example.com Springer, Private Bag 65901, Mairangi Bay, 0754 Auckland, New Zealand
Drugs – Springer Journals
Published: May 30, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera